ERNA
Eterna Therapeutics Inc
NASDAQ: ERNA · HEALTHCARE · BIOTECHNOLOGY
$0.15
-21.24% today
Updated 2026-04-30
Market cap
$5.59M
P/E ratio
—
P/S ratio
1,275.37x
EPS (TTM)
$-2.24
Dividend yield
—
52W range
$0 – $4
Volume
1.1M
Eterna Therapeutics Inc (ERNA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32.98M | $25.81M | $25.31M | $23.87M | $24.06M | $23.75M | $26.05M | $24.52M | $22.31M | $21.27M | $23.34M | $19.81M | $5.80M | $0.00 | $0.00 | $68000.00 | $582000.00 | $0.00 |
| Revenue growth (YoY) | — | -21.7% | -2.0% | -5.7% | +0.8% | -1.3% | +9.7% | -5.9% | -9.0% | -4.7% | +9.7% | -15.1% | -70.7% | -100.0% | — | — | +755.9% | -100.0% |
| Cost of revenue | — | $919000.00 | $665000.00 | $891000.00 | $721000.00 | $733000.00 | $605000.00 | $13.06M | $8.13M | $7.09M | $8.38M | $7.84M | $98000.00 | $459000.00 | $497000.00 | $236000.00 | $96000.00 | $263000.00 |
| Gross profit | $32.98M | $24.89M | $24.64M | $22.98M | $23.34M | $23.02M | $25.44M | $11.46M | $14.18M | $14.19M | $14.95M | $11.96M | $-98000.00 | $-459000.00 | $-497000.00 | $-168000.00 | $486000.00 | $-263000.00 |
| Gross margin | 100.0% | 96.4% | 97.4% | 96.3% | 97.0% | 96.9% | 97.7% | 46.7% | 63.6% | 66.7% | 64.1% | 60.4% | -1.7% | — | — | -247.1% | 83.5% | — |
| R&D | — | — | — | — | — | — | — | — | — | $139000.00 | $72000.00 | $26000.00 | $3.95M | $12.71M | $10.39M | $5.92M | $4.60M | $4.16M |
| SG&A | — | — | — | — | — | — | — | — | — | — | — | — | $3.30M | $14.72M | $16.55M | $14.59M | $13.13M | $5.16M |
| Operating income | $-1.36M | $-1.50M | $-325000.00 | $-3.28M | $-1.06M | $-1.12M | $-4.74M | $-6.60M | $-2.28M | $-1.40M | $464000.00 | $-1.21M | $-7.25M | $-113.73M | $-33.22M | $-21.14M | $-15.67M | $-9.32M |
| Operating margin | -4.1% | -5.8% | -1.3% | -13.7% | -4.4% | -4.7% | -18.2% | -26.9% | -10.2% | -6.6% | 2.0% | -6.1% | -125.0% | — | — | -31080.9% | -2693.1% | — |
| EBITDA | — | $4.80M | $5.52M | $2.17M | $5.20M | $6.56M | $5.81M | $-3.63M | $609000.00 | $915000.00 | $3.23M | $1.40M | $-26.39M | $-121.95M | $-24.01M | $-19.93M | $-36.12M | $-9.06M |
| EBITDA margin | 0.0% | 18.6% | 21.8% | 9.1% | 21.6% | 27.6% | 22.3% | -14.8% | 2.7% | 4.3% | 13.8% | 7.1% | -455.0% | — | — | -29314.7% | -6206.0% | — |
| EBIT | $-1.36M | $-1.66M | $-543000.00 | $-3.63M | $-956000.00 | $-1.13M | $-5.34M | $-6.73M | $-2.28M | $-1.40M | $464000.00 | $-1.77M | $-26.49M | $-122.41M | $-24.50M | $-21.06M | $-37.76M | $-9.32M |
| Interest expense | — | $66000.00 | $101000.00 | $52000.00 | $44000.00 | $26000.00 | $223000.00 | $484000.00 | $576000.00 | $498000.00 | $389000.00 | $249000.00 | $43000.00 | $74000.00 | $30000.00 | $614000.00 | $6.75M | $27000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-4.77M | $-1.50M | $-400000.00 | $-3.42M | $-995000.00 | $-1.05M | $-5.03M | $-7.23M | $-2.92M | $-1.08M | $-259000.00 | $-2.05M | $11.91M | $-122.55M | $-24.58M | $-21.67M | $-44.54M | $-14.10M |
| Net income growth (YoY) | — | +68.6% | +73.4% | -754.8% | +70.9% | -5.8% | -377.7% | -43.7% | +59.5% | +63.2% | +76.0% | -690.3% | +681.6% | -1129.3% | +79.9% | +11.8% | -105.6% | +68.3% |
| Profit margin | -14.5% | -5.8% | -1.6% | -14.3% | -4.1% | -4.4% | -19.3% | -29.5% | -13.1% | -5.1% | -1.1% | -10.3% | 205.3% | — | — | -31864.7% | -7652.7% | — |